Showing results (381-390 of 439) with videos related to

Sort By:
Pageof 44
Blood Advances|June 9, 2026
Prognostic factors and survival outcomes in relapsed/refractory aggressive B-cell lymphomas treated with epcoritamabAllison M Bock, Lei Feng, Ayushi Chauhan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 28, 2023
ROSEWOOD: A Phase II Randomized Study of Zanubrutinib Plus Obinutuzumab Versus Obinutuzumab Monotherapy in Patients With Relapsed or Refractory Follicular LymphomaPier Luigi Zinzani, Jiří Mayer, Christopher R Flowers, et al.
Leukemia|September 20, 2022
Impact of conditioning chemotherapy on lymphocyte kinetics and outcomes in LBCL patients treated with CAR T-cell therapyPaolo Strati, Andrew P Jallouk, Ryan Sun, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 12, 2017
Allogeneic Hematopoietic Cell Transplantation for Adult T Cell Acute Lymphoblastic LeukemiaBetty Ky Hamilton, Lisa Rybicki, Donna Abounader, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 11, 2022
Smart Start: Rituximab, Lenalidomide, and Ibrutinib in Patients With Newly Diagnosed Large B-Cell LymphomaJason Westin, R Eric Davis, Lei Feng, et al.
Blood Cancer Discovery|June 24, 2026
A Patient-Derived Xenograft Repository Capturing Clinical and Molecular Heterogeneity of Large B-cell LymphomaHaopeng Yang, Kotaro Arita, Kevin Bowman, et al.
Blood Advances|January 31, 2022
Improving eligibility criteria for first-line trials for patients with DLBCL using a US-based Delphi-method surveyR Andrew Harkins, Sharvil P Patel, Michelle J Lee, et al.
Blood|July 23, 2025
TCA cycle mode switch determines the fate of pirtobrutinib-tolerant persister cells in mantle cell lymphomaWei Wang, Qingsong Cai, Yang Liu, et al.
Cancer|November 20, 2023
Safety and efficacy of ibrutinib in combination with rituximab and lenalidomide in previously untreated follicular and marginal zone lymphoma: An open label, phase 2 studyMax J Gordon, Lei Feng, Paolo Strati, et al.
Biorxiv : the Preprint Server for Biology|February 6, 2026
A patient derived xenograft repository capturing clinical and molecular heterogeneity of large B-cell lymphomaHaopeng Yang, Kotaro Arita, Kevin Bowman, et al.
Pageof 44